Precision Care in Cardiac Arrest: ICECAP (PRECICECAP) Study Protocol and Informatics Approach.
Precision Care in Cardiac Arrest: ICECAP (PRECICECAP) Study Protocol and Informatics Approach.
复制标题
心脏骤停中的精准护理:ICECAP (PRECICECAP) 研究方案和信息学方法。
DOI:
10.1007/s12028-022-01464-9
复制
发表时间:
2022-08
影响因子:
3.5
通讯作者:
中科院分区:
文献类型:
--
作者:
Most trials in critical care have been neutral, in part because between-patient heterogeneity means not all patients respond identically to the same treatment. The PREcision Care In Cardiac arrest – ICECAP (PRECICECAP) study will apply machine learning to high-resolution, multimodality data collected from patients resuscitated from out-of-hospital cardiac arrest (OCHA). We aim to discover novel biomarker signatures to predict optimal duration of therapeutic hypothermia and 90-day functional outcomes. In parallel, we are developing a freely available software platform for standardized curation of ICU-acquired data for ML applications. The Influence of Cooling duration on Efficacy in Cardiac Arrest Patients (ICECAP) study is a response-adaptive dose-finding trial testing different durations of therapeutic hypothermia. Twelve ICECAP sites will collect data for PRECICECAP from multiple modalities routinely used after OHCA, including ICECAP case report forms, detailed medication data, cardiopulmonary and electroencephalographic waveforms, and imaging DICOMs. We partnered with Moberg Analytics to develop a freely available software platform to allow high-resolution critical care data to be used efficiently and effectively. We will use an auto-encoder neural network to create low-dimensional representations of all raw waveforms and derivative features, censored at rewarming to ensure clinical usability to guide optimal duration of hypothermia. We will also consider simple features historically considered to be important. Finally, we will create a supervised deep learning neural network algorithm to directly predict 90-day functional outcome from large sets of novel features. PRECICECAP is currently enrolling and will be completed in late 2025. Cardiac arrest is a heterogeneous disease causing substantial morbidity and mortality. PRECICECAP will advance the overarching goal of titrating personalized neurocritical care based on robust measures of individual need and treatment responsiveness. The software platform we develop will be broadly applicable to hospital-based research after acute illness or injury.
登录
查看更多内容
影响因子:
6.5
作者:
Elmer, Jonathan;Jones, Bobby L.;Nagin, Daniel
通讯作者:
Nagin, Daniel
影响因子:
38.9
作者:
Nolan JP;Sandroni C;Böttiger BW;Cariou A;Cronberg T;Friberg H;Genbrugge C;Haywood K;Lilja G;Moulaert VRM;Nikolaou N;Olasveengen TM;Skrifvars MB;Taccone F;Soar J
通讯作者:
Soar J
影响因子:
6.5
作者:
Elmer, Jonathan;Coppler, Patrick J.;Callaway, Clifton W.
通讯作者:
Callaway, Clifton W.
影响因子:
158.5
作者:
Nielsen, Niklas;Wettersley, Jorn;Friberg, Hans
通讯作者:
Friberg, Hans
影响因子:
158.5
作者:
Bernard, SA;Gray, TW;Smith, K
通讯作者:
Smith, K